MicroRNA-1291 Is Associated With Locoregional Metastases in Patients With Early-Stage Breast Cancer

MicroRNA-1291 Is Associated With Locoregional Metastases in Patients With Early-Stage Breast Cancer

Evidence that microRNAs (miRNAs) regulate the various steps of metastasis is increasing. Several studies have looked at the miRNA expression profile in primary breast tumors but few have compared primary tumor and sentinel lymph node (SLN) metastasis. We correlated the expression of miRNAs with the...

Full description

Bibliographic Details
Main Authors:	Daniel Escuin, Laura López-Vilaró, Olga Bell, Josefina Mora, Antonio Moral, José Ignacio Pérez, Cristina Arqueros, Teresa Ramón y Cajal, Enrique Lerma, Agustí Barnadas
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-12-01
Series:	Frontiers in Genetics
Subjects:	axillary lymph node dissection breast cancer sentinel lymph node metastasis microRNAs
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2020.562114/full

Similar Items

Circulating microRNAs in Early Breast Cancer Patients and Its Association With Lymph Node Metastases
by: Daniel Escuin, et al.
Published: (2021-08-01)

Circulating miRNA Expression Is Inversely Correlated with Tumor Tissue or Sentinel Lymph Nodes in Estrogen Receptor-Positive Early Breast Cancer Patients
by: Daniel Escuin, et al.
Published: (2023-08-01)

Small Non-Coding RNAs and Their Role in Locoregional Metastasis and Outcomes in Early-Stage Breast Cancer Patients
by: Daniel Escuin, et al.
Published: (2024-04-01)

Image-Guided Localization Techniques for Metastatic Axillary Lymph Nodes in Breast Cancer; What Radiologists Should Know
by: Valerio Di Paola, et al.
Published: (2023-04-01)

Sentinel Node Ratio as a Predictor of Non-sentinel Lymph Node Involvement
by: Reza Parsaei, et al.
Published: (2014-11-01)

Necessity of Low Partial Axillary Lymph Node Dissection for Breast Cancer Patients with Negative Result of Sentinel Lymph Node Biopsy
by: LIU Xuan, et al.
Published: (2018-12-01)

USEFULNESS AND PREDICTIVE POWER OF MEMORIAL SLOAN-KETTERING CANCER CENTER NOMOGRAM IN NON-SENTINEL LYMPH NODE METASTASES OUT OF SENTINEL LYMPH NODE METASTASED BREAST CANCER PATIENTS
by: Ali Aktekin, et al.
Published: (2009-10-01)

De-escalating axillary surgery in early-stage breast cancer
by: Eliza H. Hersh, et al.
Published: (2022-03-01)

Independent risk factors for axillary lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes
by: Wei Zhang, et al.
Published: (2020-07-01)

Reevaluating Axillary Lymph Node Dissection in Total Mastectomy for Low Axillary Burden Breast Cancer: Insights from a Meta-Analysis including the SINODAR-ONE Trial
by: Munaser Alamoodi, et al.
Published: (2024-02-01)

Is Sentinel Lymph Node Biopsy for Breast Cancer with Cytology-Proven Axillary Metastasis Safe? A Prospective Single-Arm Study
by: Hee Jun Choi, et al.
Published: (2021-10-01)

Validating the ACOSOG Z0011 Trial Result: A Population-Based Study Using the SEER Database
by: Jiwoong Jung, et al.
Published: (2020-04-01)

Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis
by: Yu-Jia Fan, et al.
Published: (2023-07-01)

Risk factors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes
by: HOU Xiaosa, YANG Zhenjiang
Published: (2021-06-01)

Trends in axillary surgery and clinical outcomes among breast cancer patients with sentinel node metastasis
by: Zongchao Gou, et al.
Published: (2022-06-01)

Analysis of factors related to non-sentinel lymph node metastasis in 296 sentinel lymph node-positive Chinese breast cancer patients
by: Amina Maimaitiaili, et al.
Published: (2018-09-01)

The Adventure of Axillary Treatment in Early Stage Breast Cancer
by: Bekir Kuru
Published: (2020-01-01)

Evaluation of Late Postural Complications in Breast Cancer Patients Undergoing Breast-Conserving Therapy in Relation to the Type of Axillary Intervention-Cross-Sectional Study
by: Iwona Głowacka-Mrotek, et al.
Published: (2021-04-01)

Axillary management in patients with clinical node-negative early breast cancer and positive sentinel lymph node: a systematic review and meta-analysis
by: Changzai Li, et al.
Published: (2024-01-01)

Sentinel node biopsy in breast cancer: results in a large series
by: S.M.T. Carvalho, et al.
Published: (2010-06-01)

Diagnosis and Treatment of Axillary Web Syndrome: An Overview
by: Elan YANG, et al.
Published: (2020-06-01)

Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial era
by: Yue Liang, et al.
Published: (2019-02-01)

An improved nomogram including elastography for the prediction of non-sentinel lymph node metastasis in breast cancer patients with 1 or 2 sentinel lymph node metastases
by: Hongtao Duan, et al.
Published: (2023-06-01)

The analysis of axillary lymph nodes metastasis after neoadjuvant therapy in breast cancer
by: BI Zhao, CHEN Peng, QIU Pengfei, CHEN Yuguang, WANG Yongsheng
Published: (2023-04-01)

Axillary Surgical Attitude Changing with Retrospective Application of ACOSOG Z0011 Eligible Criteria: An Institutional Evaluation
by: C. Florin Pop, et al.
Published: (2023-10-01)

Concordance between Axillary Ultrasound and Sentinel Biopsy in Clinically Node-Negative Early Breast Cancer
by: Afroz Mushtaq, et al.
Published: (2023-10-01)

A novel nomogram for decision-making assistance on exemption of axillary lymph node dissection in T1–2 breast cancer with only one sentinel lymph node metastasis
by: Lei Liu, et al.
Published: (2022-09-01)

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
by: Jana de Boniface, et al.
Published: (2017-05-01)

Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node
by: Gilles Houvenaeghel, et al.
Published: (2018-11-01)

Risk Factors Associated With Sentinel Lymph Node Metastasis in Clinically Node-Negative Breast Cancer
by: Hussain Adnan Abdulla, et al.
Published: (2023-07-01)

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
by: Hee Jun Choi, et al.
Published: (2022-11-01)

Assessment and Management of Axillary Lymph Nodes for Breast Cancer Under Concept of Precision Therapy
by: WANG Yu, et al.
Published: (2022-10-01)

Most frequent location of the sentinel lymph nodes
by: Chiao Lo, et al.
Published: (2014-07-01)

Tailored axillary surgery – A novel concept for clinically node positive breast cancer
by: Martin Heidinger, et al.
Published: (2023-06-01)

Feasibility and accuracy of targeted axillary dissection in breast cancer patients; single center experience
by: Cemal Kaya, et al.
Published: (2024-01-01)

Risk of Lymphedema and Death after Lymph Node Dissection with Neoadjuvant and Adjuvant Treatments in Patients with Breast Cancer: An Eight-Year Nationwide Cohort Study
by: Ye-Seul Lee, et al.
Published: (2023-06-01)

Research progress of axillary de-escalation management after neoadjuvant chemotherapy for clinical lymph node positive patients
by: FAN Qingda, CONG Binbin, CHEN Yuguang, DUAN Baowei, WANG Yongsheng
Published: (2023-02-01)

The Effects of Modified Lymphoscintigraphy Techniques on Sentinel Lymph Node Biopsy Success During the COVID-19 Pandemic Period
by: Cemil Yüksel, et al.
Published: (2022-02-01)

MORBIDITIES AFTER LOCAL/REGIONAL TREATMENT OF BREAST CANCER AND PATIENTS’ QUALITY OF LIFE
by: Beyza Özçınar, et al.
Published: (2010-01-01)

Axillary Lymph Node Dissection Can Be Omitted in Breast Cancer Patients With Mastectomy and False-Negative Frozen Section in Sentinel Lymph Node Biopsy
by: Jing Si, et al.
Published: (2022-04-01)